INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Aptensio XR in a safe place to prevent misuse and abuse. Selling or giving away Aptensio XR may harm others and is against the law. Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

What is ADHD?

ADHD is a common medical condition that affects more than 10% of children in the United States. Children with ADHD may have behavioral issues that they cannot control, such as trouble sitting still, finishing tasks, or paying attention.

THERE ARE 3 MAIN TYPES (PRESENTATIONS) OF ADHD
1
Predominantly hyperactive-impulsive
2
Predominantly inattentive
3
Combined hyperactive-impulsive and inattentive

Who has ADHD?

Nearly 17 million Americans are affected by ADHD.

ADHD is approximately twice as common in boys than in girls. In general, boys with ADHD are more likely to be hyperactive and girls are more likely to be inattentive.

ADHD is often inherited within families. For example, adults who have ADHD are more likely to have children who experience similar symptoms.

If you have concerns about how ADHD may affect your family, talk to your child's doctor.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Aptensio XR in a safe place to prevent misuse and abuse.